Novimmune SA
Novimmune SA, headquartered in Switzerland (CH), is a pioneering biotechnology company specialising in the development of innovative therapeutic antibodies. Founded in 2007, Novimmune has made significant strides in the biopharmaceutical industry, focusing on areas such as oncology and autoimmune diseases. The company is renowned for its proprietary antibody discovery platform, which enables the creation of unique, high-affinity antibodies tailored to target specific disease mechanisms. Novimmune's commitment to advancing healthcare is reflected in its robust pipeline of clinical candidates, positioning it as a key player in the global biotechnology landscape. With a strong emphasis on research and development, Novimmune continues to achieve notable milestones, contributing to the evolution of targeted therapies and improving patient outcomes worldwide.
DitchCarbon Score
How does Novimmune SA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Novimmune SA's score of 26 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Novimmune SA's reported carbon emissions
Novimmune SA, headquartered in Switzerland (CH), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Novimmune may not have publicly committed to specific climate initiatives or emissions reduction strategies at this time. In the context of the biopharmaceutical industry, many companies are increasingly adopting science-based targets and sustainability commitments to address climate change. However, without specific emissions data or commitments from Novimmune, it is unclear how the company aligns with these industry trends. As the landscape of corporate climate responsibility evolves, it will be important for Novimmune to consider establishing measurable targets and reporting frameworks to enhance transparency and accountability in their environmental impact.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Novimmune SA is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
